Since the U.S. Supreme Court ended federal protections for abortion last June, the Biden administration has been promoting the idea that women’s access to contraceptives is in jeopardy. In remarks last July when he issued his Executive Order on Protecting Access to Reproductive Healthcare Services, Biden vowed, “My administration will also protect a woman’s access to medications that are approved by the Food and Drug Administration — the FDA — like contraception, which is essential for preventative healthcare.”

However, no state abortion laws ban birth control. Is Biden’s argument just a red herring, or is it concealing a veiled admission of abortifacient potential in contraceptives?

A recent FDA announcement helps answer that question. On December 23 the agency issued a Decisional Memorandum about levonorgestrel emergency contraception (LNG-EC), well known by the brand name Plan B One-Step. It is an over-the-counter “morning after” pill that women can take within 72 hours of intercourse. 

This fantastic article is for subscribers only.

Login

Username/Email Address

Password

Remember Me

Lost Password?

JBS Member or ShopJBS.org Customer?

Sign in with your ShopJBS.org account username and password or use that login to subscribe.

Subscribe Now

Use code SUB25 at check out

• 24 Issues Per Year
• Digital Edition Access
• Exclusive Subscriber Content
• Audio provided for all articles
• Unlimited access to past issues
• Cancel anytime.
• Renews automatically

Subscribe Now

Use code SUB25 at check out

• 24 Issues Per Year
• Print edition delivery (USA)
  *Available Outside USA
• Digital Edition Access
• Exclusive Subscriber Content
• Audio provided for all articles
• Unlimited access to past issues
• Cancel anytime.
• Renews automatically